Belite Bio, Inc Cash Equivalents, at Carrying Value
Belite Bio, Inc (BLTE) had Cash Equivalents, at Carrying Value of $15.64 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-31
- 2025-12-31: Cash Equivalents, at Carrying Value $15.64M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $15.64M 20-F · filed 2026-03-31 |